Abstract
Epstein-Barr virus infects resting B cells in vitro and activates them to continuously proliferating lymphoblasts. Activation is essential for the virus to convert its linear genome to the covalently closed circular episomal form in which it persists in proliferating cells. However, in vivo, Epstein-Barr virus persists in resting B cells. We found that in these cells also the virus is present as an episome, suggesting that the cells must, at some time, have been activated and then returned to a resting state. This is the first direct demonstration, for any herpesvirus, of this form of the viral genome in normal persistently infected tissue. Since no linear viral DNA was detected, we estimate that fewer than 1 in 40 cells replicates the virus in the peripheral blood of healthy donors.
MeSH Terms
B-Lymphocytes/virology
Base Sequence
Cell Line
DNA Primers
DNA, Viral/blood
Genome, Viral
Herpesvirus 4, Human/genetics,isolation & purification,physiology
Humans
Molecular Sequence Data
Polymerase Chain Reaction
Virus Latency
Virus Replication
Chemicals
DNA Primers
DNA, Viral
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Decker L L
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Klaman L D
Thorley-Lawson D A
References (15)
15 references, click to expand
-
Partial purification of the Epstein-Barr virus and some properties of its DNA.
Virology. 1970 Mar;40(3):776-9
PMID: 4314514
-
A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.
J Virol. 1995 Jun;69(6):3752-8
PMID: 7745723
-
Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.
J Virol. 1984 Apr;50(1):248-54
PMID: 6321792
-
Early events in Epstein-Barr virus infection provide a model for B cell activation.
J Exp Med. 1985 Jul 1;162(1):45-59
PMID: 2989413
-
Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.
J Virol. 1986 Feb;57(2):446-55
PMID: 3003377
-
B cell activation and the establishment of Epstein-Barr virus latency.
J Exp Med. 1988 Dec 1;168(6):2059-75
PMID: 2848918
-
When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.
J Virol. 1991 Mar;65(3):1245-54
PMID: 1847452
-
Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities.
Int J Cancer. 1991 May 10;48(2):253-7
PMID: 1850387
-
Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes.
J Virol. 1992 Jun;66(6):3715-24
PMID: 1316478
-
Epstein-Barr virus strategy in normal and neoplastic B cells.
Cell. 1994 Jun 17;77(6):791-3
PMID: 8004668
-
Epstein-Barr virus: adaptation to a life within the immune system.
Trends Microbiol. 1994 Apr;2(4):125-30
PMID: 8012755
-
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
J Virol. 1994 Nov;68(11):7374-85
PMID: 7933121
-
A novel form of Epstein-Barr virus latency in normal B cells in vivo.
Cell. 1995 Feb 24;80(4):593-601
PMID: 7532548
-
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.
Immunity. 1995 Feb;2(2):155-66
PMID: 7895172
-
Detection of Epstein-Barr viral genome in nonproductive cells.
Nat New Biol. 1971 Sep 22;233(38):103-6
PMID: 4328798